导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -4.85% | 700/1050 |
| 近一周 | -2.18% | 482/1104 |
| 近一月 | -1.45% | 185/1102 |
| 近一季 | 0.34% | 235/1092 |
| 近半年 | -5.46% | 629/1070 |
| 近一年 | 3.52% | 504/1018 |
| 近两年 | 35.15% | 635/926 |
| 近三年 | 20.46% | 489/834 |
| 成立以来 | 180.20% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.89% 809/1070 |
-1.66% 732/1101 |
- - |
- - |
| 2025 | 20.73% 654/1065 |
-1.52% 880/1014 |
1.72% 536/1038 |
13.98% 766/1050 |
5.73% 111/1065 |
| 2024 | 14.90% 176/1011 |
4.14% 130/960 |
2.20% 185/983 |
11.38% 514/991 |
-3.07% 544/1011 |
| 2023 | -7.98% 275/952 |
3.62% 399/880 |
-2.74% 356/895 |
-0.86% 110/915 |
-7.89% 748/952 |
| 2022 | -9.95% 86/867 |
-11.19% 131/773 |
3.91% 585/806 |
-6.67% 101/845 |
4.55% 229/867 |
| 2021 | 5.35% 297/740 |
4.74% 50/580 |
0.25% 541/659 |
-5.63% 373/704 |
6.32% 170/740 |
| 2020 | 72.60% 132/554 |
-3.38% 242/419 |
27.20% 159/466 |
22.24% 37/517 |
14.89% 206/554 |
| 2019 | 50.68% 143/410 |
24.21% 766/1146 |
-1.00% 439/1228 |
6.16% 178/390 |
15.42% 47/410 |
| 2018 | -30.39% 222/349 |
- - |
-9.69% 468/990 |
-1.55% 275/1000 |
-13.16% 750/1080 |
| 2017 | 26.49% 56/285 |
- - |
- - |
- - |
- - |
| 2016 | -3.46% 38/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 嘉实低价策略股票 VS. 东吴新产业精选股票A(580008) |